Recombinant DNA Technology Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026

September 2020 | 150 pages | ID: RE1D1E8CD770EN
OG Analysis

Abstracts

The study predicts the short term and long term trends that can shape up the future of the Recombinant DNA Technology market including the COVID-19 pandemic implications for Recombinant DNA Technologys industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets and companies.

The Recombinant DNA Technology market forecast report identifies growth opportunities in the market and how companies are reacting to the current market conditions. Recombinant DNA Technology Companies are focusing on improving efficiency and containing costs in current COVID-19 market conditions. Recombinant DNA Technology market forecast and Recombinant DNA Technology market growth is outlook through 2026.

The report reflects on predictions with 2019 as the base year and 2020- 2026 as the forecast period. The research was based on the findings of expert team of analysts analyzing the Recombinant DNA Technology market opportunities, underlying market factors, demographic and economic factors, market developments and others.

Recombinant DNA Technology industry size is estimated to register strong growth over the forecast period driven by ongoing investments in product diversification and expansion strategies in developing countries in Asia Pacific and South and Central America while opting for strengthening Recombinant DNA Technology market share in developed countries.

Scope of the research-

Global Recombinant DNA Technology Market is analyzed and forecast over the outlook period from 2020 to 2026 By Product including Type
Recombinant Proetin Drugs
Insulin
Human Growth Harmone
Erythropoietin
Interferon
Blood Factors
Colony Stimulating Factors
Fusion Proteins
Others
Vaccines
Genetically Modified Crops
Expression Systems
Prokaryotic Cells
Mammalian Cells
Yeats
Insect
Others
Cell and Gene Therapy
Gene Editing

Global Recombinant DNA Technology Market is analyzed and forecast over the outlook period from 2020 to 2026 By application including
Therapeutics
Agriculture
Research


Top Companies Operating in Recombinant DNA Technology market include- Amgen , Biogen , Merck , Monsanto , Pfizer , Profacgen , Sanofi , Thermofisher Scientific

Contents

1. TABLE OF CONTENTS

1.1 List of Tables
1.2 List of Figures

2. EXECUTIVE SUMMARY

2.1 Report Guide
2.2 Methodology
2.3 Market Segmentation
2.4 Recombinant DNA Technology Market- Key Findings, 2020

3. STRATEGIC IMPERATIVES ON GLOBAL RECOMBINANT DNA TECHNOLOGY MARKET

3.1 COVID-19 Impact Analysis
3.2 Market Trends- Across Types, Applications, End User Types, Countries
3.3 Insights into Main Market Categories
3.4 Market Drivers and Restraints
3.5 Growth Opportunities Critical for Future Success
3.6 Key Recombinant DNA Technology Companies

4. GLOBAL RECOMBINANT DNA TECHNOLOGY MARKET VALUE OUTLOOK TO 2026 OUTLOOK BY PRODUCT TYPE

4.1 Recombinant Proetin Drugs
  4.1.1 Insulin
  4.1.2 Human Growth Harmone
  4.1.3 Erythropoietin
  4.1.4 Interferon
  4.1.5 Blood Factors
  4.1.6 Colony Stimulating Factors
  4.1.7 Fusion Proteins
  4.1.8 Others
4.2 Vaccines
4.3 Genetically Modified Crops
4.4 Expression Systems
  4.4.1 Prokaryotic Cells
  4.4.2 Mammalian Cells
  4.4.3 Yeats
  4.4.4 Insect
  4.4.5 Others
4.5 Cell and Gene Therapy
4.6 Gene Editing

5. GLOBAL RECOMBINANT DNA TECHNOLOGY MARKET VALUE OUTLOOK TO 2026 OUTLOOK BY APPLICATION

5.1 Therapeutics
5.2 Agriculture
5.3 Research

6 ASIA PACIFIC RECOMBINANT DNA TECHNOLOGY MARKET VALUE OUTLOOK TO 2026

6.1 Leading Recombinant DNA Technology Types contributing to Asia Pacific market
6.2 Top Applications contributing to Asia Pacific Recombinant DNA Technology
6.3 Top countries contributing to Asia Pacific Recombinant DNA Technology

7 EUROPE RECOMBINANT DNA TECHNOLOGY MARKET VALUE OUTLOOK TO 2026

7.1 Leading Recombinant DNA Technology Types contributing to Europe market
7.2 Top Applications contributing to Europe Recombinant DNA Technology
7.3 Top countries contributing to Europe Recombinant DNA Technology

8 NORTH AMERICA RECOMBINANT DNA TECHNOLOGY MARKET VALUE OUTLOOK TO 2026

8.1 Leading Recombinant DNA Technology Types contributing to North America market
8.2 Top Applications contributing to North America Recombinant DNA Technology
8.3 Top countries contributing to North America Recombinant DNA Technology

9 SOUTH AND CENTRAL AMERICA RECOMBINANT DNA TECHNOLOGY MARKET VALUE OUTLOOK TO 2026

9.1 Leading Recombinant DNA Technology Types contributing to South and Central America market
9.2 Top Applications contributing to South and Central America Recombinant DNA Technology
9.3 Top countries contributing to South and Central America Recombinant DNA Technology

10 MIDDLE EAST AFRICA RECOMBINANT DNA TECHNOLOGY MARKET VALUE OUTLOOK TO 2026

10.1 Leading Recombinant DNA Technology Types contributing to Middle East Africa market
10.2 Top Applications contributing to Middle East Africa Recombinant DNA Technology
10.3 Top countries contributing to Middle East Africa Recombinant DNA Technology

11 BUSINESS PROFILES OF LEADING COMPANIES

11.1 Business Description, SWOT and Financial Analysis of Companies in Recombinant DNA Technology market
11.2 Amgen
11.3 Biogen
11.4 Merck
11.5 Monsanto
11.6 Pfizer
11.7 Profacgen
11.8 Sanofi
11.9 Thermofisher Scientific

12 RECENT INDUSTRY DEVELOPMENTS

13 APPENDIX

13.1 OGAnalysis Expertise
13.2 Sources and Methodology
13.3 Contacts